microarray gene expression data (Agilent technologies)
Agilent technologies is a verified supplier 
Agilent technologies manufactures this product 
90
Structured Review
Agilent technologies
microarray gene expression data
Microarray Gene Expression Data, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+expression+microarray+data/pm38924548-289-1-0
Average 90 stars, based on 1 article reviews
Microarray Gene Expression Data, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+expression+microarray+data/pm38924548-289-1-0
Average 90 stars, based on 1 article reviews
microarray gene expression data - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Gene Expression:Article Title: FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis Article Snippet: .. Article Title: Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme Article Snippet: .. The Agilent Article Title: Estrogen Regulation of microRNAs, Target Genes, and microRNA Expression Associated with Vitellogenesis in the Zebrafish Article Snippet: .. Article Title: A plasmablast biomarker for nonresponse to antibody therapy to CD20 in rheumatoid arthritis. Article Snippet: n M ay 1 9, 2 01 5 An important goal for personalized health care is the identification of biomarkers that predict the likelihood of treatment responses.. Here, we tested the hypothesis that quantitative mRNA assays for B lineage cells in blood could serve as baseline predictors of therapeutic response to B cell depletion therapy in subjects with rheumatoid arthritis (RA).. In samples from the REFLEX trial of rituximab in inadequate responders to antibodies to tumor necrosis factor–a, a 25% subgroup of treated subjects with elevated baseline mRNA levels of IgJ, a marker for antibody-secreting plasmablasts, showed reduced clinical response rates. Article Title: Identification of glioblastoma immune subtypes and immune landscape based on a large cohort Article Snippet: .. The processed Agilent Microarray:Article Title: FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis Article Snippet: .. Article Title: Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme Article Snippet: .. The Agilent Article Title: Estrogen Regulation of microRNAs, Target Genes, and microRNA Expression Associated with Vitellogenesis in the Zebrafish Article Snippet: .. Article Title: A plasmablast biomarker for nonresponse to antibody therapy to CD20 in rheumatoid arthritis. Article Snippet: n M ay 1 9, 2 01 5 An important goal for personalized health care is the identification of biomarkers that predict the likelihood of treatment responses.. Here, we tested the hypothesis that quantitative mRNA assays for B lineage cells in blood could serve as baseline predictors of therapeutic response to B cell depletion therapy in subjects with rheumatoid arthritis (RA).. In samples from the REFLEX trial of rituximab in inadequate responders to antibodies to tumor necrosis factor–a, a 25% subgroup of treated subjects with elevated baseline mRNA levels of IgJ, a marker for antibody-secreting plasmablasts, showed reduced clinical response rates. Article Title: Identification of glioblastoma immune subtypes and immune landscape based on a large cohort Article Snippet: .. The processed Agilent Software:Article Title: Estrogen Regulation of microRNAs, Target Genes, and microRNA Expression Associated with Vitellogenesis in the Zebrafish Article Snippet: .. Flow Cytometry:Article Title: A plasmablast biomarker for nonresponse to antibody therapy to CD20 in rheumatoid arthritis. Article Snippet: n M ay 1 9, 2 01 5 An important goal for personalized health care is the identification of biomarkers that predict the likelihood of treatment responses.. Here, we tested the hypothesis that quantitative mRNA assays for B lineage cells in blood could serve as baseline predictors of therapeutic response to B cell depletion therapy in subjects with rheumatoid arthritis (RA).. In samples from the REFLEX trial of rituximab in inadequate responders to antibodies to tumor necrosis factor–a, a 25% subgroup of treated subjects with elevated baseline mRNA levels of IgJ, a marker for antibody-secreting plasmablasts, showed reduced clinical response rates. Generated:Article Title: A plasmablast biomarker for nonresponse to antibody therapy to CD20 in rheumatoid arthritis. Article Snippet: n M ay 1 9, 2 01 5 An important goal for personalized health care is the identification of biomarkers that predict the likelihood of treatment responses.. Here, we tested the hypothesis that quantitative mRNA assays for B lineage cells in blood could serve as baseline predictors of therapeutic response to B cell depletion therapy in subjects with rheumatoid arthritis (RA).. In samples from the REFLEX trial of rituximab in inadequate responders to antibodies to tumor necrosis factor–a, a 25% subgroup of treated subjects with elevated baseline mRNA levels of IgJ, a marker for antibody-secreting plasmablasts, showed reduced clinical response rates. |